Tempest Therapeutics Inc. (NASDAQ: TPST) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TEMPEST THERAPEUTICS INC.

Tempest Therapeutics Inc. (NASDAQ: TPST)
Listen to this Section


$0.98
+0.0070 ( +0.72% ) 128.1K

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Market Data


Open $0.98
Previous Close $0.97
Volume 128.1K
Market Cap $15.55M
Day Range $1.01 - $1.12
52 Week Range $0.95 - $6.12
Shares Outstanding 15.98M
Change % +0.72%
Net Change ▲ 0.0070
Insider Ownership -0.15%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -2,038,328.00

Date Type Amount Purchased Purchaser
2024-01-05 Sale -26500.00 Trojanowski Justin
2024-01-05 Sale -40000.00 Maestas Nicholas
2023-10-13 Sale -100000.00 Maestas Nicholas
2023-10-13 Sale -725000.00 Brady Stephen R
2023-10-13 Sale -55000.00 Trojanowski Justin
2023-10-13 Sale -325000.00 Whiting Samuel

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 Nov 05, 2025
10-q Quarterly Reports 60 Nov 05, 2025
8-k 8K-related 12 Aug 11, 2025
10-q Quarterly Reports 66 Aug 11, 2025

Latest News